Nigel H. Greig

32.1k total citations · 9 hit papers
431 papers, 25.6k citations indexed

About

Nigel H. Greig is a scholar working on Molecular Biology, Pharmacology and Physiology. According to data from OpenAlex, Nigel H. Greig has authored 431 papers receiving a total of 25.6k indexed citations (citations by other indexed papers that have themselves been cited), including 139 papers in Molecular Biology, 137 papers in Pharmacology and 119 papers in Physiology. Recurrent topics in Nigel H. Greig's work include Cholinesterase and Neurodegenerative Diseases (127 papers), Alzheimer's disease research and treatments (99 papers) and Computational Drug Discovery Methods (58 papers). Nigel H. Greig is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (127 papers), Alzheimer's disease research and treatments (99 papers) and Computational Drug Discovery Methods (58 papers). Nigel H. Greig collaborates with scholars based in United States, Taiwan and Saudi Arabia. Nigel H. Greig's co-authors include Debomoy K. Lahiri, David Tweedie, Kumar Sambamurti, Harold W. Holloway, Mark P. Mattson, Yazhou Li, TracyAnn Perry, Mohammad Amjad Kamal, Qian‐sheng Yu and Josephine M. Egan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Nigel H. Greig

421 papers receiving 25.1k citations

Hit Papers

Mitophagy inhibits amyloi... 2005 2026 2012 2019 2019 2017 2005 2017 2009 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease
    2019 1.3k citations Nigel H. Greig, Mark P. Mattson et al. profile →
  2. Mitophagy and Alzheimer’s Disease: Cellular and Molecular Mechanisms
    2017 649 citations Nigel H. Greig, Mark P. Mattson et al. profile →
  3. Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent
    2005 645 citations Nigel H. Greig, Harold W. Holloway et al. Proceedings of the National Academy of Sciences profile →
  4. Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
    2017 603 citations Yazhou Li, Nigel H. Greig et al. profile →
  5. GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism
    2009 502 citations Yazhou Li, Mark S. Kindy et al. Proceedings of the National Academy of Sciences profile →
  6. Running-Induced Systemic Cathepsin B Secretion Is Associated with Memory Function
    2016 417 citations Nigel H. Greig et al. profile →
  7. Drug discovery and development: Role of basic biological research
    2017 377 citations Nigel H. Greig et al. profile →
  8. Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment
    2022 152 citations Elliot J. Glotfelty, Yazhou Li et al. profile →
  9. The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial
    2023 72 citations Nigel H. Greig, Yazhou Li et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Nigel H. Greig 8.8k 6.9k 6.2k 4.4k 3.9k 431 25.6k
Moussa B. H. Youdim 10.0k 1.1× 7.6k 1.1× 6.3k 1.0× 10.2k 2.3× 12.4k 3.2× 553 37.1k
Debomoy K. Lahiri 7.1k 0.8× 7.5k 1.1× 4.5k 0.7× 3.0k 0.7× 1.3k 0.3× 319 20.7k
Martin R. Farlow 8.0k 0.9× 12.5k 1.8× 6.9k 1.1× 3.2k 0.7× 2.9k 0.7× 375 26.9k
Xiongwei Zhu 13.5k 1.5× 14.5k 2.1× 4.2k 0.7× 4.4k 1.0× 3.0k 0.8× 345 28.6k
William R. Markesbery 17.0k 1.9× 22.1k 3.2× 4.9k 0.8× 5.8k 1.3× 5.1k 1.3× 404 49.9k
Khalid Iqbal 15.0k 1.7× 21.9k 3.2× 5.1k 0.8× 7.6k 1.7× 3.1k 0.8× 375 32.8k
Inge Grundke‐Iqbal 15.2k 1.7× 21.7k 3.2× 4.9k 0.8× 7.5k 1.7× 3.2k 0.8× 280 31.7k
D. Allan Butterfield 12.4k 1.4× 13.4k 1.9× 4.0k 0.6× 3.4k 0.8× 1.5k 0.4× 286 27.8k
Agneta Nordberg 10.2k 1.2× 10.8k 1.6× 6.0k 1.0× 6.6k 1.5× 1.8k 0.5× 503 25.9k
Sam Gandy 8.1k 0.9× 13.2k 1.9× 3.3k 0.5× 3.7k 0.8× 2.2k 0.6× 292 21.5k

Countries citing papers authored by Nigel H. Greig

Since Specialization
Citations

This map shows the geographic impact of Nigel H. Greig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nigel H. Greig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nigel H. Greig more than expected).

Fields of papers citing papers by Nigel H. Greig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nigel H. Greig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nigel H. Greig. The network helps show where Nigel H. Greig may publish in the future.

Co-authorship network of co-authors of Nigel H. Greig

This figure shows the co-authorship network connecting the top 25 collaborators of Nigel H. Greig. A scholar is included among the top collaborators of Nigel H. Greig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nigel H. Greig. Nigel H. Greig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sebastian, Sneha Annie, et al.. (2025). Balancing hope and heart: An umbrella review of cardiotoxicity in immune checkpoint inhibitor cancer therapies. Current Problems in Cardiology. 51(3). 103257–103257.
2.
Luo, Weiming, David Tweedie, Cindy H. Chau, et al.. (2025). Monoterpenoid fluorophthalimide IMiDs that lack human cereblon binding: synthesis and anti-proliferative, anti-angiogenic and anti-inflammatory activities. Biochemical and Biophysical Research Communications. 779. 152428–152428.
3.
Chen, Kai‐Yun, Shih‐Chang Hsueh, David Tweedie, et al.. (2025). 3-Monothiopomalidomide, a new immunomodulatory imide drug (IMiD), blunts inflammation and mitigates ischemic stroke in the rat. GeroScience. 47(4). 5763–5783. 1 indexed citations
4.
Li, Yazhou, et al.. (2024). Incretin-Based Multi-Agonist Peptides Are Neuroprotective and Anti-Inflammatory in Cellular Models of Neurodegeneration. Biomolecules. 14(7). 872–872. 9 indexed citations
5.
Glotfelty, Elliot J., Shih‐Chang Hsueh, David Tweedie, et al.. (2023). A New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative Disorders. Biomolecules. 13(5). 747–747. 13 indexed citations
6.
Glotfelty, Elliot J., Shih‐Chang Hsueh, Binhai Zheng, et al.. (2023). Microglial Nogo delays recovery following traumatic brain injury in mice. Glia. 71(10). 2473–2494. 4 indexed citations
7.
8.
Baig, Abdul Mannan, et al.. (2022). Underlying Causes and Treatment Modalities for Neurological Deficits in COVID-19 and Long-COVID. ACS Chemical Neuroscience. 13(20). 2934–2938. 2 indexed citations
9.
Delgado‐Peraza, Francheska, Carlos Nogueras‐Ortiz, Olga V. Volpert, et al.. (2021). Neuronal and Astrocytic Extracellular Vesicle Biomarkers in Blood Reflect Brain Pathology in Mouse Models of Alzheimer’s Disease. Cells. 10(5). 993–993. 55 indexed citations
10.
Peach, Megan L., Shaunna Beedie, Cindy H. Chau, et al.. (2020). Antiangiogenic Activity and in Silico Cereblon Binding Analysis of Novel Thalidomide Analogs. Molecules. 25(23). 5683–5683. 14 indexed citations
11.
Scerba, Michael T., David Tweedie, Nigel H. Greig, et al.. (2019). Post-Injury Neuroprotective Effects of the Thalidomide Analog 3,6′-Dithiothalidomide on Traumatic Brain Injury. International Journal of Molecular Sciences. 20(3). 502–502. 27 indexed citations
12.
Li, Yazhou, Kelli L. Vaughan, David Tweedie, et al.. (2019). Pharmacokinetics of Exenatide in nonhuman primates following its administration in the form of sustained-release PT320 and Bydureon. Scientific Reports. 9(1). 17208–17208. 18 indexed citations
13.
Li, Yazhou, Daniela Lecca, Vardit Rubovitch, et al.. (2018). Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury. Neurobiology of Disease. 124. 439–453. 27 indexed citations
14.
Luo, Weiming, David Tweedie, Shaunna Beedie, et al.. (2018). Design, synthesis and biological assessment of N-adamantyl, substituted adamantyl and noradamantyl phthalimidines for nitrite, TNF-α and angiogenesis inhibitory activities. Bioorganic & Medicinal Chemistry. 26(8). 1547–1559. 16 indexed citations
15.
Greig, Nigel H. & Debomoy K. Lahiri. (2014). Advances in understanding Alzheimer's disease, and the contributions of current Alzheimer research: ten years on and beyond. IUScholarWorks (Indiana University). 1 indexed citations
16.
Greig, Nigel H., David Tweedie, Lital Rachmany, et al.. (2014). Incretin mimetics as pharmacological tools to elucidate and as a new drug strategy to treat traumatic brain injury. PMC. 25 indexed citations
17.
Li, Yazhou, Mark S. Kindy, Brandon K. Harvey, et al.. (2009). GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism. Proceedings of the National Academy of Sciences. 106(4). 1285–1290. 502 indexed citations breakdown →
18.
Doyle, Maı̀re E., et al.. (2000). Exendin-4 Decelerates Food Intake, Weight Gain, and Fat Deposition in Zucker Rats. Endocrinology. 141(6). 1936–1941. 253 indexed citations
19.
Neuwelt, Edward A., N. Joan Abbott, Lester R. Drewes, et al.. (1999). Cerebrovascular Biology and the Various Neural Barriers: Challenges and Future Directions. Neurosurgery. 44(3). 604–608. 34 indexed citations
20.
Neuwelt, Edward A., N. Joan Abbott, Lester R. Drewes, et al.. (1999). Cerebrovascular biology and the various neural barriers. Neurosurgery. 44(3).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Moussa B. H. Youdim Breakdown of academic impact, for papers by Debomoy K. Lahiri Breakdown of academic impact, for papers by Martin R. Farlow Breakdown of academic impact, for papers by Xiongwei Zhu Breakdown of academic impact, for papers by William R. Markesbery Breakdown of academic impact, for papers by Khalid Iqbal Breakdown of academic impact, for papers by Inge Grundke‐Iqbal Breakdown of academic impact, for papers by D. Allan Butterfield Breakdown of academic impact, for papers by Agneta Nordberg Breakdown of academic impact, for papers by Sam Gandy
Rankless by CCL
2026